In a report issued on January 4, Steven Valiquette from Barclays maintained a Hold rating on AmerisourceBergen Corporation (ABC), with a price target of $84. The company’s shares closed on Friday at $74.22, close to its 52-week low of $69.36.
According to TipRanks.com, Valiquette is a 4-star analyst with an average return of 4.1% and a 48.2% success rate. Valiquette covers the Services sector, focusing on stocks such as Patterson Companies Inc, WellCare Health Plans, and Molina Healthcare.
The word on The Street in general, suggests a Hold analyst consensus rating for AmerisourceBergen Corporation with a $91.40 average price target.
See today’s analyst top recommended stocks >>
Based on AmerisourceBergen Corporation’s latest earnings release for the quarter ending September 30, the company reported a quarterly net profit of $233 million. In comparison, last year the company had a net profit of $862 million.
Based on the recent corporate insider activity of 83 insiders, corporate insider sentiment is negative on the stock. Most recently, in November 2018, Lazarus Krikorian, the SVP of ABC sold 20,276 shares for a total of $1,832,342.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
AmerisourceBergen Corp. engages provision of pharmaceutical products and business solutions that improve access to care. It operates through the Pharmaceutical Distribution Services and Other segments.
